Agnes Rey-Giraud
CIK 1235685 · President, International Ops · last filed 2026-06-17
Agnes Rey-Giraud is a President, International Ops who has filed 49 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for GDRX, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$18.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ESRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GDRX | Director | 426,286 | $3.02 | $1.29M | -$5.29M | 13 | 2026-06-17 |
| UpHealth, Inc. (UPH.WS) Delisted | Director | 144,057 | $0.01 | $1.2K | $0 | 3 | 2021-12-23 |
| EXPRESS SCRIPTS INC (ESRX) Delisted | President, International Ops | 91,968 | — | — | -$13.52M | 31 | 2011-03-04 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| GDRX | Direct | 426,286 | 100.0% | 2026-06-17 |
| By ARG Family Legacy Trust #1 | 0 | 0.0% | 2026-03-13 | |
| Total | 426,286 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | GDRX | Grant (A) | +73,434 | $0 | EDGAR |
| 2026-03-13 | GDRX | Mixed | +192,185 | $90.3K | EDGAR |
| 2025-08-19 | GDRX | Gift (G) | — | $0 | EDGAR |
| 2025-06-04 | GDRX | Grant (A) | +57,050 | $0 | EDGAR |
| 2024-07-10 | GDRX | Grant (A) | +2,464 | $0 | EDGAR |
| 2024-06-10 | GDRX | Grant (A) | +28,398 | $0 | EDGAR |
| 2024-06-07 | — | Sell (S) | −13,282 | -$8.0K | |
| 2024-02-02 | — | Grant (A) | +100,000 | $0 | |
| 2023-06-15 | GDRX | Grant (A) | +39,177 | $0 | EDGAR |
| 2022-06-16 | GDRX | Grant (A) | +27,440 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).